Zacks Investment Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-662
Closed -$205K 808
2025
Q3
$205K Sell
662
-26,075
-98% -$8.17M ﹤0.01% 680
2025
Q2
$8.4M Sell
26,737
-3,828
-13% -$1.1M 0.07% 181
2025
Q1
$8.03M Sell
30,565
-1,703
-5% -$461K 0.07% 184
2024
Q4
$8.42M Sell
32,268
-218
-0.7% -$54.9K 0.08% 177
2024
Q3
$7.56M Sell
32,486
-1,222
-4% -$251K 0.07% 184
2024
Q2
$6.8M Buy
33,708
+1,471
+5% +$265K 0.08% 169
2024
Q1
$5.53M Sell
32,237
-57,551
-64% -$10.7M 0.06% 193
2023
Q4
$19.5M Buy
+89,788
New +$15.4M 0.24% 108
2023
Q3
Sell
-6,358
Closed -$1.83M 686
2023
Q2
$1.83M Buy
+6,358
New +$1.93M 0.02% 299
2022
Q4
Sell
-8,821
Closed -$2.02M 649
2022
Q3
$2.02M Buy
+8,821
New +$2.21M 0.03% 264
2021
Q1
Sell
-7,001
Closed -$1.79M 562
2020
Q4
$1.79M Buy
+7,001
New +$1.74M 0.03% 278

Other funds holding PODD

Zacks Investment Management's PODD Position: Q4 2025 in Review

Zacks Investment Management sold out of Insulet (PODD) in Q4 2025, closing a stake of 662 shares — an estimated $205K sold.

Zacks Investment Management first reported a position in PODD in Q4 2020 and held it in 11 quarters. The position peaked at $19.5M in Q4 2023. 833 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

  • Zacks Investment Management reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
  • Zacks Investment Management sold 662 Insulet shares in Q4 2025, an estimated $205K.
  • Zacks Investment Management first reported a position in Insulet in Q4 2020 and held it in 11 quarters.
  • Zacks Investment Management's Insulet position peaked at $19.5M in Q4 2023.
  • 833 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on Zacks Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.